Discovery of Pyrazolone Carbothioamide Derivatives as Inhibitors of the Pdr1-KIX Interaction for Combinational Treatment of Azole-Resistant Candidiasis
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.3c00488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Qingwen Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Ningxia Medical University, Yinchuan 750004, China. Hauptthemen laut MEDLINE: Candidiasis, Pyrazolones. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Shanghai Municipal Education Commission, Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Candida glabrata has emerged as an important opportunistic pathogen of invasive candidiasis due to increasing drug resistance. Targeting Pdr1-KIX interactions with small molecules represents a potential strategy for treating drug-resistant candidiasis. However, effective Pdr1-KIX inhibitors are rather limited, hindering the validation of target druggability. Here, new Pdr1-KIX inhibitors were designed and assayed. Particularly, compound B8 possessed a new chemical scaffold and exhibited potent KIX binding affinity, leading to enhanced synergistic efficacy with fluconazole to treat resistant C. glabrata infection (FICI = 0.28). Compound B8 acted by inhibiting the efflux pump and down-regulating resistance-associated genes through blocking the Pdr1-KIX interaction. Compound B8 exhibited excellent in vitro and in vivo antifungal potency in combination with fluconazole against azole-resistant C. glabrata. It also had direct antifungal effect to treat C. glabrata infection, suggesting new mechanisms of action independent of Pdr1-KIX inhibition. Therefore, compound B8 represents a promising lead compound for antifungal drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Ningxia Medical University, Yinchuan 750004, China.
- The Center for Basic Research and Innovation of Medicine and Pharmacy (MOE), School of Pharmacy, Second Military Medical University (Naval Medical University), Shanghai 200433, China.
ORCID-Profile: Na Liu, Chunquan Sheng
Förderung
- Shanghai Municipal Education Commission
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
Zitieren
APA
Wang, Q., Tu, J., Yang, W., Liang, T., Liu, N., & Sheng, C. (2023). Discovery of Pyrazolone Carbothioamide Derivatives as Inhibitors of the Pdr1-KIX Interaction for Combinational Treatment of Azole-Resistant Candidiasis. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c00488
Vancouver
Wang Q, Tu J, Yang W, Liang T, Liu N, Sheng C. Discovery of Pyrazolone Carbothioamide Derivatives as Inhibitors of the Pdr1-KIX Interaction for Combinational Treatment of Azole-Resistant Candidiasis. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c00488
BibTeX
@article{Wang2023,
author = {Wang, Qingwen and Tu, Jie and Yang, Wanzhen and Liang, Tingting and Liu, Na and Sheng, Chunquan},
title = {Discovery of Pyrazolone Carbothioamide Derivatives as Inhibitors of the Pdr1-KIX Interaction for Combinational Treatment of Azole-Resistant Candidiasis},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.3c00488}
}
EUVIMED